Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease

Neurobiology of Disease

Volumn 21, Issue 2, 2006, Pages 392-403

  Shehadeh, Jacqueline ^a,b   Fernandes, Herman B ^a,b   Zeron Mullins, Melinda M ^a,b   Graham, Rona K ^a   Leavitt, Blair R ^a,b   Hayden, Michael R ^a,b   Raymond, Lynn A ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Apoptosis; Excitotoxicity; Mitochondria; Primary neuronal culture

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; POLYGLUTAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL FUNCTION; CONTROLLED STUDY; EXCITOTOXICITY; HUNTINGTON CHOREA; NERVE CELL CULTURE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSGENIC MOUSE; YEAST ARTIFICIAL CHROMOSOME;

ANIMALS; APOPTOSIS; CALCIUM; CELLS, CULTURED; CHROMOSOMES, ARTIFICIAL, YEAST; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; HUMANS; HUNTINGTON DISEASE; IN SITU NICK-END LABELING; MICE; MICE, TRANSGENIC; MITOCHONDRIA; NEURONS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 30744437894     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2005.08.001     Document Type: Article

References (68)

1. K.M. Abdel-Hamid, and K.G. Baimbridge The effects of artificial calcium buffers on calcium responses and glutamate-mediated excitotoxicity in cultured hippocampal neurons Neuroscience 81 1997 673 687
2. C.C. Alano, G. Beutner, R.T. Dirksen, R.A. Gross, and S.S. Sheu Mitochondrial permeability transition and calcium dynamics in striatal neurons upon intense NMDA receptor activation J. Neurochem. 80 2002 531 538
3. R.L. Albin, and J.T. Greenamyre Alternative excitotoxic hypotheses Neurology 42 1992 733 738
4. R.L. Albin, A.B. Young, J.B. Penney, B. Handelin, R. Balfour, K.D. Anderson, D.S. Markel, W.W. Tourtellotte, and A. Reiner Abnormalities of striatal projection neurons and N-methyl-d-aspartate receptors in presymptomatic Huntington's disease [see comments] N. Engl. J. Med. 322 1990 1293 1298
5. M.F. Beal Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31 1992 119 130
6. M.F. Beal, N.W. Kowall, D.W. Ellison, M.F. Mazurek, K.J. Swartz, and J.B. Martin Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid Nature 321 1986 168 171
7. R. Bertrand, E. Solary, P. O'Connor, K.W. Kohn, and Y. Pommier Induction of a common pathway of apoptosis by staurosporine Exp. Cell Res. 211 1994 314 321
8. S.E. Browne, A.C. Bowling, U. MacGarvey, M.J. Baik, S.C. Berger, M.M. Muqit, E.D. Bird, and M.F. Beal Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia Ann. Neurol. 41 1997 646 653
9. S.L. Budd, L. Tenneti, T. Lishnak, and S.A. Lipton Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons Proc. Natl. Acad. Sci. U. S. A. 97 2000 6161 6166
10. E. Cattaneo, D. Rigamonti, D. Goffredo, C. Zuccato, F. Squitieri, and S. Sipione Loss of normal huntingtin function: new developments in Huntington's disease research Trends Neurosci. 24 2001 182 188
11. C. Cepeda, M.A. Ariano, C.R. Calvert, J. Flores-Hernandez, S.H. Chandler, B.R. Leavitt, M.R. Hayden, and M.S. Levine NMDA receptor function in mouse models of Huntington disease J. Neurosci. Res. 66 2001 525 539
12. J.H. Cha Transcriptional dysregulation in Huntington's disease Trends Neurosci. 23 2000 387 392
13. N. Chen, T. Luo, C. Wellington, M. Metzler, K. McCutcheon, M.R. Hayden, and L.A. Raymond Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin J. Neurochem. 72 1999 1890 1898
14. Y.S. Choo, G.V. Johnson, M. MacDonald, P.J. Detloff, and M. Lesort Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release Hum. Mol. Genet. 13 2004 1407 1420
15. S.W. Davies, M. Turmaine, B.A. Cozens, M. DiFiglia, A.H. Sharp, C.A. Ross, E. Scherzinger, E.E. Wanker, L. Mangiarini, and G.P. Bates Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation Cell 90 1997 537 548
16. M. DiFiglia, E. Sapp, K.O. Chase, S.W. Davies, G.P. Bates, J.P. Vonsattel, and N. Aronin Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain Science 277 1997 1990 1993
17. R.J. Ferrante, N.W. Kowall, M.F. Beal, J.B. Martin, E.D. Bird, and E.P. Richardson Jr. Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease J. Neuropathol. Exp. Neurol. 46 1987 12 27
18. R.J. Ferrante, O.A. Andreassen, A. Dedeoglu, K.L. Ferrante, B.G. Jenkins, S.M. Hersch, and M.F. Beal Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease J. Neurosci. 22 2002 1592 1599
19. J. Flores-Hernandez, C. Cepeda, E. Hernandez-Echeagaray, C.R. Calvert, E.S. Jokel, A.A. Fienberg, P. Greengard, and M.S. Levine Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32 J. Neurophysiol. 88 2002 3010 3020
20. F.R. Fusco, Q. Chen, W.J. Lamoreaux, G. Figueredo-Cardenas, Y. Jiao, J.A. Coffman, D.J. Surmeier, M.G. Honig, L.R. Carlock, and A. Reiner Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease J. Neurosci. 19 1999 1189 1202
21. J. Gafni, and L.M. Ellerby Calpain activation in Huntington's disease J. Neurosci. 22 2002 4842 4849
22. G.M. Goellner, and M. Rechsteiner Are Huntington's and polyglutamine-based ataxias proteasome storage diseases? Int. J. Biochem. Cell Biol. 35 2003 562 571
23. D. Goffredo, D. Rigamonti, M. Tartari, A. De Micheli, C. Verderio, M. Matteoli, C. Zuccato, and E. Cattaneo Calcium-dependent cleavage of endogenous wild-type huntingtin in primary cortical neurons J. Biol. Chem. 277 2002 39594 39598
24. J.G. Greene, R.H. Porter, R.V. Eller, and J.T. Greenamyre Inhibition of succinate dehydrogenase by malonic acid produces an "excitotoxic" lesion in rat striatum J. Neurochem. 61 1993 1151 1154
25. M. Gu, M.T. Gash, V.M. Mann, F. Javoy-Agid, J.M. Cooper, and A.H. Schapira Mitochondrial defect in Huntington's disease caudate nucleus Ann. Neurol. 39 1996 385 389
26. S. Gunawardena, L.S. Her, R.G. Brusch, R.A. Laymon, I.R. Niesman, B. Gordesky-Gold, L. Sintasath, N.M. Bonini, and L.S. Goldstein Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila Neuron 40 2003 25 40
27. A.S. Hackam, R. Singaraja, C.L. Wellington, M. Metzler, K. McCutcheon, T. Zhang, M. Kalchman, and M.R. Hayden The influence of huntingtin protein size on nuclear localization and cellular toxicity J. Cell Biol. 141 1998 1097 1105
28. O. Hansson, A. Peters n, M. Leist, P. Nicotera, R.F. Castilho, and P. Brundin Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity Proc. Natl. Acad. Sci. U. S. A. 96 1999 8727 8732
29. G.E. Hardingham, S. Chawla, F.H. Cruzalegui, and H. Bading Control of recruitment and transcription-activating function of CBP determines gene regulation by NMDA receptors and L-type calcium channels Neuron 22 1999 789 798
30. J.G. Hodgson, D.J. Smith, K. McCutcheon, H.B. Koide, K. Nishiyama, M.B. Dinulos, M.E. Stevens, N. Bissada, J. Nasir, I. Kanazawa, C.M. Disteche, E.M. Rubin, and M.R. Hayden Human huntingtin derived from YAC transgenes compensates for loss of murine huntingtin by rescue of the embryonic lethal phenotype Hum. Mol. Genet. 5 1996 1875 1885
31. J.G. Hodgson, N. Agopyan, C.A. Gutekunst, B.R. Leavitt, F. LePiane, R. Singaraja, D.J. Smith, N. Bissada, K. McCutcheon, J. Nasir, L. Jamot, X.J. Li, M.E. Stevens, E. Rosemond, J.C. Roder, A.G. Phillips, E.M. Rubin, S.M. Hersch, and M.R. Hayden A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration Neuron 23 1999 181 192
32. Huntington Study Group A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease Neurology 57 2001 397 404
33. Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes Cell 72 1993 971 983
34. Y.J. Kim, Y. Yi, E. Sapp, Y. Wang, B. Cuiffo, K.B. Kegel, Z.H. Qin, N. Aronin, and M. DiFiglia Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis Proc. Natl. Acad. Sci. U. S. A. 98 2001 12784 12789
35. J.Y. Koh, M.B. Wie, B.J. Gwag, S.L. Sensi, L.M. Canzoniero, J. Demaro, C. Csernansky, and D.W. Choi Staurosporine-induced neuronal apoptosis Exp. Neurol. 135 1995 153 159
36. A.D. Kovacs, G. Cebers, A. Cebere, T. Moreira, and S. Liljequist Cortical and striatal neuronal cultures of the same embryonic origin show intrinsic differences in glutamate receptor expression and vulnerability to excitotoxicity Exp. Neurol. 168 2001 47 62
37. A.J. Krohn, T. Wahlbrink, and J.H. Prehn Mitochondrial depolarization is not required for neuronal apoptosis J. Neurosci. 19 1999 7394 7404
38. U. Kumar Characterization of striatal cultures with the effect of QUIN and NMDA Neurosci. Res. 49 2004 29 38
39. U. Kumar, K. Asotra, S.C. Patel, and Y.C. Patel Expression of NMDA receptor-1 (NR1) and huntingtin in striatal neurons which colocalize somatostatin, neuropeptide Y, and NADPH diaphorase: a double-label histochemical and immunohistochemical study Exp. Neurol. 145 1997 412 424
40. B.R. Leavitt, J.A. Guttman, J.G. Hodgson, G.H. Kimel, R. Singaraja, A.W. Vogl, and M.R. Hayden Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo Am. J. Hum. Genet. 68 2001 313 324
41. L. Li, T.H. Murphy, M.R. Hayden, and L.A. Raymond Enhanced striatal NR2B-containing N-methyl-d-aspartate receptor-mediated synaptic currents in a mouse model of Huntington disease J. Neurophysiol. 92 2004 2738 2746
42. D. Martindale, A. Hackam, A. Wieczorek, L. Ellerby, C. Wellington, K. McCutcheon, R. Singaraja, P. Kazemi-Esfarjani, R. Devon, S.U. Kim, D.E. Bredesen, F. Tufaro, and M.R. Hayden Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates Nat. Genet. 18 1998 150 154
43. A.V. Panov, C.A. Gutekunst, B.R. Leavitt, M.R. Hayden, J.R. Burke, W.J. Strittmatter, and J.T. Greenamyre Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines Nat. Neurosci. 5 2002 731 736
44. T.I. Peng, and J.T. Greenamyre Privileged access to mitochondria of calcium influx through N-methyl-d-aspartate receptors Mol. Pharmacol. 53 1998 974 980
45. T.I. Peng, M.J. Jou, S.S. Sheu, and J.T. Greenamyre Visualization of NMDA receptor-induced mitochondrial calcium accumulation in striatal neurons Exp. Neurol. 149 1998 1 12
46. J.H. Prehn, J. Jordan, G.D. Ghadge, E. Preis, M.F. Galindo, R.P. Roos, J. Krieglstein, and R.J. Miller Ca2+ and reactive oxygen species in staurosporine-induced neuronal apoptosis J. Neurochem. 68 1997 1679 1685
47. A.C. Rego, and C.R. Oliveira Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases Neurochem. Res. 28 2003 1563 1574
48. A. Reiner, R.L. Albin, K.D. Anderson, C.J. D'Amato, J.B. Penney, and A.B. Young Differential loss of striatal projection neurons in Huntington disease Proc. Natl. Acad. Sci. U. S. A. 85 1988 5733 5737
49. L.L. Rubin Neuronal cell death: an updated view Prog. Brain Res. 117 1998 3 8
50. P.R. Sanberg, S.F. Calderon, M. Giordano, J.M. Tew, and A.B. Norman The quinolinic acid model of Huntington's disease: locomotor abnormalities Exp. Neurol. 105 1989 45 53
51. E. Sapp, J. Penney, A. Young, N. Aronin, J.P. Vonsattel, and M. DiFiglia Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease J. Neuropathol. Exp. Neurol. 58 1999 165 173
52. R. Sattler, M.P. Charlton, M. Hafner, and M. Tymianski Distinct influx pathways, not calcium load, determine neuronal vulnerability to calcium neurotoxicity J. Neurochem. 71 1998 2349 2364
53. A. Sawa, G.W. Wiegand, J. Cooper, R.L. Margolis, A.H. Sharp, J.F. Lawler Jr., J.T. Greenamyre, S.H. Snyder, and C.A. Ross Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization Nat. Med. 5 1999 1194 1198
54. E. Scherzinger, R. Lurz, M. Turmaine, L. Mangiarini, B. Hollenbach, R. Hasenbank, G.P. Bates, S.W. Davies, H. Lehrach, and E.E. Wanker Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo Cell 90 1997 549 558
55. W.X. Shi, and S. Rayport GABA synapses formed in vitro by local axon collaterals of nucleus accumbens neurons J. Neurosci. 14 1994 4548 4560
56. E.J. Slow, J. van Raamsdonk, D. Rogers, S.H. Coleman, R.K. Graham, Y. Deng, R. Oh, N. Bissada, S.M. Hossain, Y.Z. Yang, X.J. Li, E.M. Simpson, C.A. Gutekunst, B.R. Leavitt, and M.R. Hayden Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease Hum. Mol. Genet. 12 2003 1555 1567
57. G. Szebenyi, G.A. Morfini, A. Babcock, M. Gould, K. Selkoe, D.L. Stenoien, M. Young, P.W. Faber, M.E. MacDonald, M.J. McPhaul, and S.T. Brady Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport Neuron 40 2003 41 52
58. T.S. Tang, H. Tu, E.Y. Chan, A. Maximov, Z. Wang, C.L. Wellington, M.R. Hayden, and I. Bezprozvanny Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1, 4, 5) triphosphate receptor type 1 Neuron 39 2003 227 239
59. T.S. Tang, E. Slow, V. Lupu, I.G. Stavrovskaya, M. Sugimori, R. Llinas, B.S. Kristal, M.R. Hayden, and I. Bezprozvanny Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease Proc. Natl. Acad. Sci. U. S. A. 102 2005 2602 2607
60. J.M. Van Raamsdonk, J. Pearson, E.J. Slow, S.M. Hossain, B.R. Leavitt, and M.R. Hayden Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease J. Neurosci. 25 2005 4169 4180
61. J.P. Vonsattel, and M. DiFiglia Huntington disease J. Neuropathol. Exp. Neurol. 57 1998 369 384
62. J.P. Vonsattel, R.H. Myers, T.J. Stevens, R.J. Ferrante, E.D. Bird, and E.P. Richardson Jr. Neuropathological classification of Huntington's disease J. Neuropathol. Exp. Neurol. 44 1985 559 577
63. C.L. Wellington, L.M. Ellerby, A.S. Hackam, R.L. Margolis, M.A. Trifiro, R. Singaraja, K. McCutcheon, G.S. Salvesen, S.S. Propp, M. Bromm, K.J. Rowland, T. Zhang, D. Rasper, S. Roy, N. Thornberry, L. Pinsky, A. Kakizuka, C.A. Ross, D.W. Nicholson, D.E. Bredesen, and M.R. Hayden Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract J. Biol. Chem. 273 1998 9158 9167
64. A.B. Young, J.T. Greenamyre, Z. Hollingsworth, R. Albin, C. D'Amato, I. Shoulson, and J.B. Penney NMDA receptor losses in putamen from patients with Huntington's disease Science 241 1988 981 983
65. M.M. Zeron, O. Hansson, N. Chen, C.L. Wellington, B.R. Leavitt, P. Brundin, M.R. Hayden, and L.A. Raymond Increased sensitivity to N-methyl-d-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease Neuron 33 2002 849 860
66. M.M. Zeron, H.B. Fernandes, C. Krebs, J. Shehadeh, C.L. Wellington, B.R. Leavitt, K.G. Baimbridge, M.R. Hayden, and L.A. Raymond Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease Mol. Cell. Neurosci. 25 2004 469 479
67. Y. Zhang, M. Li, M. Drozda, M. Chen, S. Ren, R.O. Mejia Sanchez, B.R. Leavitt, E. Cattaneo, R.J. Ferrante, M.R. Hayden, and R.M. Friedlander Depletion of wild-type huntingtin in mouse models of neurologic diseases J. Neurochem. 87 2003 101 106
68. C. Zuccato, A. Ciammola, D. Rigamonti, B.R. Leavitt, D. Goffredo, L. Conti, M.E. MacDonald, R.M. Friedlander, V. Silani, M.R. Hayden, T. Timmusk, S. Sipione, and E. Cattaneo Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease Science 293 2001 493 498